SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (1068)12/13/1996 10:41:00 PM
From: Sun Byun   of 4342
 
Paul, I agree. We now have to wait until March or beyond since the powers that be may be reticent for other than objective reasons and can use current events, such as Rhodes retiring, as excuses to try to effect a shakeout. For instance, todays 80,000 or so shares could easily reflect only 25,000 or so shares marked to market a few times to yeild triple that number and giving the impression that price dropped on much higher volume than was the case. The Androcar results won't be out until about March also but the real issue will be the response of the market to Androvir and to Androcar. If the market responds well then the effect of the majors and the Don Kings of the parmaceutical world is out the window. The market will prevail, I think, though that is not certain since the majors have tremendous power and will fight this niche, and try to keep it from unfolding, unless they can buy it up, in which case we will probably profit nicely but whoever buys it up may do so to bury it so they can continue to maximize their high level of profit within the extant FDA procedure.

Larry

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext